Kurt Von Emster, Director at CRISPR Therapeutics AG (CRSP), sold 125,850 shares at $29.70 ($3.7M) on 2018-12-18, disclosed to the SEC on 2019-01-18.
Open-market sale of $3.7M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.70 | 62,925 | $1.9M | 50.0% |
| 2 | $29.70 | 62,925 | $1.9M | 50.0% |
| Total | $29.70 avg | 125,850 | $3.7M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CBAY | SELL | 2018-12-19 | $2.2M | — | Filing → |